We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Inspiration Healthcare Group Plc | LSE:IHC | London | Ordinary Share | GB00BXDZL105 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 13.75 | 13.50 | 14.00 | 13.75 | 13.75 | 13.75 | 83,872 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Home Health Care Services | 37.63M | -6.03M | -0.0673 | -2.04 | 12.33M |
Date | Subject | Author | Discuss |
---|---|---|---|
18/6/2023 09:37 | Does anyone have a Times subscription to access this article? If so then I don't suppose it might be possible for someone to kindly 'cut & paste' their summary here? | brummy_git | |
22/5/2023 10:41 | Just to remind shareholders and prospective investors, Inspiration Healthcare will be presenting & exhibiting on the 24th of May this week at Mello2023. We have created a two day physical investor conference (23rd & 24th May) at the Clayton Hotel and Conference Centre in Chiswick that will include 15 top quality keynote speakers, 12 educational workshops and panel sessions, 50 exhibiting companies plus over 80 company presentations for investors to evaluate and understand their current or future investments. We will also be hosting a live BASH session, analysing lots of additional companies! For a £25 bonus add-on price delegates at Mello2023 are also invited to make it a three day visit and join us for the Mello2023 Virtual event the day after, Thursday 25th May. Tickets are still available and if you would like one at half price then enter the code MMTADVFN50. | melloteam | |
17/5/2023 11:16 | Just to let shareholders and prospective investors know that Inspiration Healthcare will be presenting & exhibiting on the 24th of May next week at Mello2023. We have created a two day physical investor conference (23rd & 24th May) at the Clayton Hotel and Conference Centre in Chiswick that will include 15 top quality keynote speakers, 12 educational workshops and panel sessions, 50 exhibiting companies plus over 80 company presentations for investors to evaluate and understand their current or future investments. For a £25 bonus add-on price delegates at Mello2023 are also invited to make it a three day visit and join us for the Mello2023 Virtual event the day after, Thursday 25th May. Tickets are still available and if you would like one at half price then enter the code MMTADVFN50. | melloteam | |
03/5/2023 14:20 | Share price not moved since early 4.4% drop. Looks like the market makers are happy to acquire shares - there's a larger buyer in background. I'm hoping the CEO buys a load here, to show his confidence in the business as they build on the last quarter sales revenue and recover from supply chain shocks | lammylover | |
03/5/2023 09:08 | Clearly some problems with the internal upheavals last year and perhaps a little closer to running out of cash than market realised but equally seem through the worst now and I can't see the point in throwing in the towel at this juncture. | gopher | |
03/5/2023 06:55 | You hope, so you can buy and sell at 60p on Friday. It's what you TRY to do. Like the left, lie for your objectives. Sleep tight | borisjohnsonshair | |
17/2/2023 18:17 | If the Cenkos forecast of 467k is the market expectations mentioned within the TU, it means that the company made a loss after tax of 299k in the second half (against profit after tax of 1.4m in the half year to January 2022). | rossco | |
17/2/2023 15:00 | Nice to see a fund (Castlefield Investment Partners) take a 3.09% stake here. Hopefully can start to move back towards 60p if they hoover up any significant amount of loose shares... | lammylover | |
16/2/2023 08:55 | Cenkos: Adj Ebitda £3.8m, Post tax profit £467k Dil EPS 0.7p | cockerhoop | |
16/2/2023 08:55 | Cenkos was at £3.8m | techno20 | |
16/2/2023 08:47 | Any ideas what the Adjusted EBITDA mkt expectations were ? | apatel21 | |
16/2/2023 08:43 | Reassuring statement and positive outlook. Hopefully marks the beginning of a recovery in the share price Cenkos positive buy recommendation out. Have topped up. | techno20 | |
09/2/2023 13:01 | Thanks for info Swerves - I wasn't aware of this. LL | lammylover | |
09/2/2023 10:47 | Good news for Inspiration today. See the Genedrive RNS this morning......their test got preliminary approval from NICE and Inspiration are the official UK and Ireland distributor for this! | swerves1 | |
07/2/2023 20:13 | 200,000 shares gone through today at midpoint 51.5p. Presumably a fund offloading via market maker to another fund. Perhaps see a holding RNS over next few days, if seller or buyer at or above 3%. | lammylover | |
06/2/2023 14:54 | Agreed, I've been adding down to 48p - there was clearly a bigger seller who wanted out, hence price fell to 2 year low. I'm expecting an RNS trade update within the next week for the FY results to end Jan 2023. Whilst these won't be great compared to previous year, the revenue will still be similar and once they've resolved the supply side issues; cut back on inventory and utilised the new manufacturing / tech centre - then the EBITDA should kick back in and push this onto 100p again. Also got the project Wave development in background. May take a year, but solid company selling non discretionary items to NHS and other countries medical services. Buy and hold for recovery. | lammylover | |
06/2/2023 14:02 | This company is chock full of valuable intellectual property and sells good quality products around the world. It has an excellent relationship with the NHS. At a price of around .52p, taking into account its medium-term potential, it seems under-priced. I have topped up. | lindowcross | |
08/12/2022 10:32 | Suspect the FD has taken the rap for the appalling management of guidance leading up to the profit warning. | cockerhoop | |
08/12/2022 10:28 | Hybrasil, Yeah the sudden departure of the FD is a worry, which I didn't forsee. I'm currently out (bought a few shares when they dropped to 53.5p then sold with the Director partner's buy. Of course this was before the FD RNS. Now looking for a better re-entry price. If I can get in below 50p, then I'll hold for a period. Turbulent times all around with inflation etc. But IHC have done well for me historically and I expect they will turn things around, once the new factory is working well. LL | lammylover | |
08/12/2022 10:18 | Lammy I’ve looked at this again and can see no catalyst for share price growth between now and the results in may. The departure of the cfo without explanation doesn’t help. If I was a betting man I would say the share has room to fall. I don’t have a position but will look again in May | hybrasil | |
07/12/2022 16:54 | The FD going seems to have prompted a further fall. | gopher | |
30/11/2022 13:42 | Sometimes a lot of work goes into office move and eye on the ball suffers. In smaller companies it is easy to outgrow premises until a move becomes a necessity for next stage of growth. Fingers crossed that the situation here. In larger companies that’s rarely the case. | gopher | |
28/11/2022 11:14 | Congratulations to those who correctly predicted and acted on red flags. Will continue to hold I suspect the share price will hold at about one times turnover until current problems resolve as a blip or something more fundamental. | gopher |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions